Summary: Researchers have redefined a key biological mechanism related to obsessive-compulsive disorder (OCD) by showing that serotonin directly reduces what they call “belief stickiness” — the tendency to persist with an outdated belief about the state of the world despite clear, contradictory evidence.
In a randomized, double-blind clinical trial, participants completed a changing-environment task while researchers used computational models to quantify how quickly they updated their internal models. A single dose of the selective serotonin reuptake inhibitor (SSRI) escitalopram raised serotonin levels and led to faster, more accurate updating of beliefs. These results challenge habit-based explanations of OCD and point to targeted windows for combining medication with psychotherapy.
Key Facts
- Belief stickiness defined: The study team defines belief stickiness as difficulty detecting that the environment has transitioned to a new state, causing a person to cling to an old interpretation even when evidence contradicts it.
- Study design: Fifty healthy volunteers were randomized to receive either a single dose of escitalopram or a placebo in a double-blind setup. Plasma escitalopram levels were measured to relate drug exposure to behavioral effects.
- The “Seasons” task: Participants played a computer game collecting shells. Some shells yielded pearls (positive points) while others contained dirt (negative points). Unannounced shifts in “seasons” changed which shells were rewarding, forcing players to infer the current state rather than rely on simple trial-and-error.
- Serotonin’s effect: Computational modeling showed that higher escitalopram plasma concentrations were associated with reduced belief stickiness and better inference about which season was active, compared with placebo.
- Implications for OCD: Rather than treating compulsive behaviors solely as automatic habits, the findings suggest OCD symptoms may reflect an information-updating deficit: patients fail to register that a state has changed, so they continue behaviors even when evidence shows the change has occurred.
- Therapeutic timing: Because a single SSRI dose produced an acute improvement in updating, the study suggests scheduling intensive psychotherapy within the pharmacological window when the brain may be most receptive to revising entrenched patterns.
Source: Brown University
Main findings
The research team, led by Frederike Petzschner of Brown University, with collaborators at institutions in Zurich and Lisbon, published their results in Nature Mental Health. They started with a computational psychiatry hypothesis: serotonin promotes cognitive flexibility by reducing belief stickiness, enabling faster revision of internal models when the environment changes.
To test this, 50 volunteers received either escitalopram or placebo and performed the shell-collecting game. The task was specifically designed to separate two types of learning: trial-and-error associations and higher-level state inference about when hidden changes occur. Player choices and outcomes were fitted with computational models to estimate belief updating parameters.
Results showed a clear relationship between plasma escitalopram levels and reduced belief stickiness. Participants with higher drug exposure inferred season changes more accurately and adapted their strategies faster than those on placebo. Although none of the participants had an OCD diagnosis, those who reported more obsessive-like thoughts during testing displayed greater belief stickiness and poorer state inference.
Escitalopram is already a frontline SSRI for OCD. The authors propose that its therapeutic effect may arise, at least in part, from improving the brain’s ability to update beliefs about the state of the world, thereby reducing the persistence of obsessive thoughts and compulsive behaviors.
Reframing OCD: from habits to inference
Traditional models interpret repetitive compulsions as learned habits. This study offers an alternative perspective: compulsions may persist because the individual’s internal model fails to recognize that conditions have changed. In practical terms, a person may repeat hand washing because their brain does not register that washing has already produced clean hands. The behavior is not merely automatic — it reflects a breakdown in belief updating.
Because a single SSRI dose can transiently enhance belief updating, the team suggests pairing medication administration with targeted psychotherapy during that same window. Doing so could allow therapists to take advantage of a period when patients are biologically more able to revise entrenched beliefs and learn alternative responses.
Funding: The study was supported by the René and Susanne Braginsky Foundation, the University of Zurich, Fundação para a Ciência e a Tecnologia (Portugal), the Tourette Association of America, and the Brainstorm Program at the Carney Institute.
Key Questions Answered:
A: The study suggests this behavior can reflect severe belief stickiness: an information-updating failure in which the brain does not register that the situation has changed. The person’s internal belief remains that their hands are dirty despite visual or sensory evidence to the contrary.
A: The game forced players to infer hidden environment states when reward contingencies flipped silently. By modeling how long players clung to old strategies after a switch, researchers could quantify belief stickiness. Higher serotonin levels corresponded with faster recognition of those switches.
A: The findings support synchronized treatment strategies: administering an SSRI to produce a short-term boost in belief updating, then delivering targeted psychotherapy during that window when the brain is more receptive to changing entrenched thought patterns.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional explanatory context was added by staff to clarify study methods and implications.
About this serotonin and OCD research news
Author: Corrie Pikul
Source: PLOS
Contact: Corrie Pikul – PLOS
Image: The image is credited to Neuroscience News
Original Research: Closed access. “Serotonin reduces belief stickiness” by Vasco A. Conceição, Frederike H. Petzschner, David M. Cole, Katharina V. Wellstein, Daniel Müller, Sudhir Raman & Tiago V. Maia. Nature Mental Health. DOI: 10.1038/s44220-026-00621-9
Abstract
Serotonin reduces belief stickiness
Serotonin promotes cognitive flexibility, but the specific mechanism has been unclear. The authors propose a computational account in which serotonin reduces belief stickiness — the tendency to remain committed to a belief about the state of the world despite incoming contradictory evidence.
They tested this hypothesis in a randomized, double-blind, placebo-controlled study using a single dose of escitalopram. Higher escitalopram plasma levels were associated with reduced belief stickiness and improved inference about the current state of the environment. Participants who reported more obsessive thoughts showed greater belief stickiness and worse state inference, suggesting a link between excessive belief stickiness and obsessions. The contrasting relations of escitalopram and obsessive tendencies with belief stickiness may help explain why SSRIs are effective in treating obsessive–compulsive disorder.